Medpace Holdings, Inc.·4

Feb 28, 4:34 PM ET

Keating Ashley M. 4

4 · Medpace Holdings, Inc. · Filed Feb 28, 2024

Insider Transaction Report

Form 4
Period: 2024-02-26
Transactions
  • Sale

    Common Stock

    2024-02-26$404.68/sh254$102,7890 total
  • Exercise/Conversion

    Common Stock

    2024-02-26$54.99/sh+500$27,495500 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-02-26500972 total
    Exercise: $54.99Exp: 2026-05-17Common Stock (500 underlying)
  • Sale

    Common Stock

    2024-02-26$403.89/sh246$99,358254 total
Footnotes (2)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
  • [F2]The option vested in full on May 14, 2020.

Documents

1 file
  • 4
    wk-form4_1709156065.xmlPrimary

    FORM 4